Loading... Please wait.

Selskapsdetaljer

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
  • pharmaceutical products (79.8%): prescription drugs in the areas of specialty medicine (63.2% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (36.8%; mainly for the treatment of diabetes and cardiovascular diseases);
  • human vaccines (20.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.
At the end of 2024, the group had 52 production sites worldwide. In October 2024, the consumer healthcare products business (Opella) was classified as a discontinued operation. Net sales are distributed geographically as follows: France (4.4%), Europe (17.6%), the United States (48.7%), China (6.5%) and other (22.8%).

Kilde: Cofisem - Sist oppdatert: 25 Mar 2025
Ledelse
Chief Executive Officer Paul Hudson
Chief Financial Officer Francois-Xavier Roger
Director Research & Development Houman Ashrafian
Chief Human Resources Officer Natalie Bickford
Chief Regulatory & Public Affairs Officer Audrey Duval
Head of Investor Relations Thomas Kudsk Larsen
General Counsel Roy Papatheodorou
Kilde: Cofisem - Sist oppdatert: 25 Mar 2025
Key figures
Millenium 2024 2023 2022 2021 2020
Net sales 41.081 37.817 42.997 37.761 36.041
Income from ordinary activities 44.286 41.618 45.389 39.175 37.369
Operating income 7.252 6.960 10.656 8.126 14.141
Cost of financial indebtedness net 186 25 124 259 225
Equity-accounted companies contribution to income 60 -136 68 39 359
Net profit from discontinued activities 64 338 0
Net income 5.618 5.436 8.484 6.279 12.350
Net income (Group share) 5.560 5.400 8.371 6.223 12.314
Fiscal year end 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - millions EUR - millions EUR - millions EUR - millions EUR - millions
Account Standards IFRS IFRS IFRS IFRS IFRS
Kilde: Cofisem - Sist oppdatert: 25 Mar 2025
Største aksjonærer
Free float 80,38 %
L'Oréal 9,36 %
BlackRock, Inc. 6,96 %
Employees 2,55 %
Treasury stock 0,75 %
Kilde: Cofisem - Sist oppdatert: 25 Mar 2025

Adresse

Sanofi

46 Avenue de la Grande Armée
FR-75017 Paris
France
Telefonnummer: +33 (0)1 53 77 40 00
https://www.sanofi.com/fr/investisseurs/
Kilde: Cofisem - Sist oppdatert: 25 Mar 2025

Kontakt

Investor Relations
investor.relations@sanofi.com
Kilde: Sanofi - Sist oppdatert: 25 Mar 2025